Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

Alastair Thompson to lead IU’s breast cancer center

Alastair Thompson was named director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s Vera Bradley Foundation Center for Breast Cancer Research.

August 07, 2026

Vol.52 No.31

Clinical Roundup

BRCA-negative patients may still be high-risk for breast cancer, study finds

Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by investigators at Cedars-Sinai Medical Center, the University of Toronto, and the University of Sydney.

August 07, 2026

Vol.52 No.31

Clinical Roundup

Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy

Researchers at the University of Kansas Cancer Center, Emory University School of Medicine, and the international Southwest Oncology Group Cancer Research Network have identified a blood biomarker that may help thousands of women with hormone receptor-positive breast cancer avoid unnecessary chemotherapy.

August 07, 2026

Vol.52 No.31

Cancer Policy

NBCC’s open letter to Ways and Means demands markup for Metastatic Breast Cancer Access to Care Act

NBCC President Fran Visco authored the following open letter to the House Ways and Means Committee, criticizing the committee for failing to bring the Metastatic Breast Cancer Access to Care Act, HR 2048, before the committee for markup.

July 24, 2026

Vol.52 No.29

By Jacquelyn Cobb

The long life of a clinical trial
How JCO sustains landmark oncology research

In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure.

July 10, 2026

Vol.52 No.27

By Journal of Clinical Oncology

Clinical Roundup

Young women diagnosed with breast cancer within three years of childbirth may face more aggressive disease, UCLA study finds

Breast cancers diagnosed during the first three years after childbirth, particularly within the first year, may be biologically more aggressive than similar cancers in women who have never given birth, according to a study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.

July 10, 2026

Vol.52 No.27

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa

With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

YOU MAY BE INTERESTED IN

Alastair Thompson to lead IU’s breast cancer center

BRCA-negative patients may still be high-risk for breast cancer, study finds

Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy

NBCC’s open letter to Ways and Means demands markup for Metastatic Breast Cancer Access to Care Act

The long life of a clinical trial
How JCO sustains landmark oncology research

Young women diagnosed with breast cancer within three years of childbirth may face more aggressive disease, UCLA study finds

Renew today!

Subscriber content

Never miss an issue!

Login

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa

With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

YOU MAY BE INTERESTED IN

Alastair Thompson to lead IU’s breast cancer center

BRCA-negative patients may still be high-risk for breast cancer, study finds

Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy

NBCC’s open letter to Ways and Means demands markup for Metastatic Breast Cancer Access to Care Act

The long life of a clinical trialHow JCO sustains landmark oncology research

Young women diagnosed with breast cancer within three years of childbirth may face more aggressive disease, UCLA study finds

Never miss an issue!

Login

The long life of a clinical trial
How JCO sustains landmark oncology research